Background and Aims: Psychotropic medicine has been suggested to be a risk factor for the onset of pneumonia, especially aspiration pneumonia. However, the impact of coexisting psychiatric disease and psychotropic medication on the outcomes of pneumonia patients in the respiratory care unit setting is less well-known.
Results: Psychotropic medicines, including agents for insomnia, were used in 73 (34.9%) patients, and there were 35 (16.9%) patients who had psychiatric disease. Among the 12 (5.7%) fatal cases, 4 patients were treated with psychotropic medicines, all of which were agents for insomnia. However, the rate of psychotropic medicine usage in the fatal cases (33.3%) was equivalent to that of the survivors (35%), and the coexistence of psychiatric disease did not affect survival. The duration of hospitalization of the patients who received psychotropic medicines (median 17 [range: 7-89] days) was also equivalent to that of the other patients (14 [2-55] days, P = 0.081).
Conclusion: While the present study was a single-centre study and had a small population, coexisting psychiatric disease and psychotropic medicine use did not have a strong impact on the outcomes of pneumonia patients who were hospitalized in the respiratory unit of a university hospital. Further prospective studies targeting a larger cohort are needed. 
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Background and Aims: Community-acquired Pneumonia (CAP) is one of the leading cause of death from infectious disease in developing countries. The prediction of outcome is important in decision-making process. Several studies to developed or evaluated scoring system has been done, but the scoring system performance was not superior in some groups of patients especially patients with comorbidity. According to the fact, we need to studied predictors that affect the 30 days mortality among CAP patients with comorbidity. The purpose of this study was to determine the predictors of 30 days mortality in CAP patients with comorbidity in the biggest referral hospital in Indonesia.
Methods: We performed a prospective cohort study among 267 CAP patients with comorbidity in Cipto Mangunkusumo Hospital between October-November 2017. Data were collected at initiation of hospitalized period and the main outcome was all-cause mortality during 30 days. Chisquare test were used to determine the association between variables. Multiple logistic regression analysis was used to determine independent risk factors for mortality. The odds ratio (ORs) and corresponding 95% confidence intervals (Cis) for each variable were calculated.
Results: Among 267 patients there were 31.5% of 30 days mortality rate. The independent predictors of mortality were confusion (P < 0.01 OR 1.7 [95% CI 1.2-2.4]), respiratory rate ≥30/min (P < 0.01 OR 3.3 [95% CI 2.5-4.4]), pulse ≥ 125/min (P < 0.01 OR 3.0 [95% CI 2.3-4.0]), low blood pressure systolic <90 mmHg or diastolic ≤ 60 mmHg (P < 0.01 OR 2.0 [95% CI 1.4-2.9]), albumin <3.5 g/dL (P 0.02 OR 2 [95% CI 1.1-3.7]), platelet count <100.000/L (P < 0.01 OR 1.8 [95% CI 1.2-2.6]).
Conclusion: Confusion, respiratory rate ≥ 30/min, pulse ≥ 125/min, low blood pressure systolic <90 mmHg or diastolic ≤ 60 mmHg, albumin <3.5 g/dL, platelet count <100,000/L were independent predictors of 30 days mortality among CAP patients with comorbidity. 
